latest news releases from the newsroom
Lundin Petroleum AB
LUNDIN PETROLEUM HAS SPUDDED EXPLORATION WELL 12/17B-1, OFFSHORE UNITED KINGDOM
Well 12/17b-1 is targeting Jurassic sandstones. The Ridgewood prospect is a
four-way dip closure. The unrisked gross potential resource is 41 million
barrels of oil equivalent (mmboe).
Lundin Petroleum has contracted the Global Santa Fe Galaxy II jack-up rig to
drill this prospect. Drilling is expected to take 28 days. Well 12/17b-1 is the
third well of a three well back-to-back exploration drilling programme on the
UKCS using the same rig.
Lundin Petroleum is the operator with 30 percent
Cytomedix Announces That CMS Preliminarily Affirms Non-Coverage of PRP Gel
ROCKVILLE, Md., Dec. 20, 2007 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that the Centers for Medicare and Medicaid Services (CMS) has proposed to reaffirm its 2003 national non-coverage decision for autologous blood derived products for chronic non-healing wounds in a draft response to a national coverage reconsideration requested by Cytomedix. CMS cited a lack of adequate evidence and a need for further study of the product in the surgical and chronic wound care setting, the setting for which Cytomedix sought the broadest national coverage.
Alphatec Holdings, Inc.
Alphatec Holdings, Inc. Acquires an Exclusive Worldwide License for Innovative Pedicle Screw Technology
CARLSBAD, Calif., Dec. 20, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spinal disorders, announced the entry into an exclusive worldwide license for an innovative pedicle screw technology that is designed to provide a fusion solution for patients who suffer from osteoporosis or poor bone density. The company's wholly owned subsidiary, Alphatec Spine, Inc. ("Alphatec Spine"), and Progressive Spinal Technologies LLC., ("Progressive") entered into an exclusive worldwide license agreement that provides Alphatec Spine the right to develop and commercialize Progressive's osteoporotic pedicle screw technology solution. The technology, which Alphatec Spine will jointly develop with Progressive, is a pedicle screw that is designed to be implanted into the pedicle and then expanded to achieve increased purchase if the surgeon desires a more secure fixation. Progressive, formed in early 2006, develops technologies for the orthopedics industry, specializing in spinal implants.
Entegris, Inc. Announces Acquisition and Employment Inducement Restricted Stock Awards
CHASKA, Minn., Dec. 20, 2007 (PRIME NEWSWIRE) -- Entegris, Inc. (Nasdaq:ENTG) today announced that employment inducement restricted stock awards covering an aggregate of 32,500 shares had been granted on December 17, 2007 to three newly hired employees of Entegris, Inc. These awards comprised: 15,000 shares granted to Justin Wang, V.P. and Managing Director for Asia; 7,500 shares granted to Jim Wiese, V.P. of Tax; and 10,000 shares granted to Larry Tan, V.P. of Human Resources for Asia. In accordance with NASDAQ Rule 4350(i)(1)(A), these restricted stock awards were made under a stock option plan without stockholder approval. Rule 4350(i)(1)(A) requires public announcement of option grants made under this type of plan.
Izard Nobel LLP
Schatz Nobel Izard P.C. Announces Class Action Lawsuit Against Huntington Bancshares Incorporated
HARTFORD, Conn., Dec. 20, 2007 (PRIME NEWSWIRE) -- The law firm of Schatz Nobel Izard P.C., which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Southern District of Ohio on behalf of all persons who purchased the common stock of Huntington Bancshares Incorporated ("Huntington" or the "Company") (Nasdaq:HBAN) between July 20, 2007 and November 16, 2007 (the "Class Period").